Arkansas Governor, Local and Community Leaders Congratulate Standard Lithium, Equinor for U.S. Department of Energy Provisional Grant up to US$225 million
September 23, 2024 08:00 ET
|
Standard Lithium
LEWISVILLE, Ark., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium”) (TSXV:SLI) (NYSE American:SLI), a leading near-commercial lithium development company and Equinor, a...
Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth
September 23, 2024 08:00 ET
|
IMPACT BIOMEDICAL INC
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
September 23, 2024 08:00 ET
|
Gabelli Funds
GREENWICH, Conn., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Gabelli Funds, LLC, a leader in value-oriented and research-driven investment management, is excited to announce its second annual PFAS...
Provident Bank Welcomes Vivin Varghese As Senior Vice President, Chief Information Security Officer
September 23, 2024 08:00 ET
|
Provident Bank
ISELIN, N.J., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, is pleased to announce that Vivin Varghese has joined the organization as Senior...
Integer Completes Two Irish Facility Expansions to Support Growth, Strengthen Capabilities in Critical Medtech Region
September 23, 2024 08:00 ET
|
Integer Holdings Corporation
PLANO, Texas, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today formally...
Theriva™ Biologics logra el objetivo de inscripción de pacientes en VIRAGE, el ensayo de Fase 2b de VCN-01 con gemcitabina/nab-paclitaxel para el tratamiento del cáncer de páncreas metastásico
September 23, 2024 08:00 ET
|
Theriva Biologics, Inc.
- Objetivo de 92 pacientes evaluables (46 en la rama de control y 46 en la rama de tratamiento con VCN-01) inscritos en 15 centros de España y EE. UU. en un plazo de 21 meses – ROCKVILLE, Maryland,...
Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
September 23, 2024 08:00 ET
|
Theriva Biologics, Inc.
- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months – ROCKVILLE, Md., Sept. 23, 2024 (GLOBE...
FTI Consulting Adds EY Global M&A Leader to Transactions Practice
September 23, 2024 07:30 ET
|
FTI Consulting, Inc.
WASHINGTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Brian Salsberg as a Senior Managing Director and Global Head of M&A in the...
Brookfield Raises $2.4 billion for Catalytic Transition Fund Supported by Anchor Commitment from ALTÉRRA
September 23, 2024 07:00 ET
|
Brookfield Asset Management Ltd
Additional capital raised from CDPQ, GIC, Prudential and Temasek, among others Targeting up to $5 billion, anchored by $1 billion catalytic capital investment by ALTÉRRA BROOKFIELD, NEWS, Sept. 23,...
Kodiak Selects Wabash’s Trailers as a Service to Optimize Its Autonomous Fleet
September 23, 2024 06:55 ET
|
Wabash National Corporation
LAFAYETTE, Ind., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Wabash (NYSE: WNC), the visionary leader of connected solutions for the transportation, logistics and distribution industries, is pleased to...